Clinical Trial Update: INCB047986 in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

The Phase 2 study of INCB047986 for rheumatoid arthritis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• INCB047986

Snippet

Sponsor: Incyte Corporation | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED